Avidity Biosciences (RNA) Fails to deliver data

Key failure to deliver metrics for Avidity Biosciences:

• Last SEC data release: 2025-11-28
• Last 15 days FTD volume: NZ$10.04 M
• Last 3 months FTD volume: NZ$28.88 M
• Last 12 months FTD volume: NZ$45.14 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Avidity Biosciences (RNA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Avidity Biosciences (RNA) - since 2020

Avidity Biosciences (RNA) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
PTC Therapeutics PTCT	NZ$3.46 M	NZ$32.41 M	🇺🇸 USA
Acorda Therapeutics ACOR	N/A	NZ$0.01 M	🇺🇸 USA
Sarepta Therapeutics SRPT	NZ$1.79 M	NZ$20.7 M	🇺🇸 USA
Catalyst Pharmaceuticals CPRX	NZ$0.17 M	NZ$0.95 M	🇺🇸 USA
Fate Therapeutics FATE	NZ$0.59 M	NZ$1.38 M	🇺🇸 USA
Pfizer PFE	NZ$29.26 M	NZ$0.10 B	🇺🇸 USA
GlaxoSmithKline GSK	NZ$61.56 M	NZ$0.39 B	🇬🇧 UK